14-day Premium Trial Subscription Sign Up For FreeGet Free

Weaker Stock
Today ABUS ranks #12835 as sell candidate. Get a Free Stock at Robinhood
Stronger Stock

Arbutus Biopharma Corporation Stock Forecast NASDAQ:ABUS

$3.31 (2.80%)

Volume: 2M

Closed: Jan 14, 2022

Hollow Logo Score: -3.054

Arbutus Biopharma Corporation Stock Forecast

$3.31 (2.80%)

Volume: 2M

Closed: Jan 14, 2022

Score Hollow Logo -3.054

Arbutus Biopharma Corporation Stock Price (Quote) NASDAQ:ABUS

$3.31 ( 2.80% ) Friday, 14th Jan 2022

Range Low Price High Price Comment
30 days $3.13 $4.50 Friday, 14th Jan 2022 ABUS stock ended at $3.31. This is 2.8% more than the trading day before Thursday, 13th Jan 2022. During the day the stock fluctuated 6.08% from a day low at $3.13 to a day high of $3.32.
90 days $3.01 $6.50
52 weeks $2.43 $6.50

Historical Arbutus Biopharma Corporation prices

Date Open High Low Close Volume
2022-01-14 $3.16 $3.32 $3.13 $3.31 2 453 213
2022-01-13 $3.33 $3.34 $3.22 $3.22 2 437 188
2022-01-12 $3.36 $3.39 $3.27 $3.30 2 107 590
2022-01-11 $3.50 $3.52 $3.35 $3.36 2 872 569
2022-01-10 $3.53 $3.59 $3.38 $3.52 2 234 034
2022-01-07 $3.56 $3.62 $3.46 $3.50 1 761 997
2022-01-06 $3.50 $3.61 $3.40 $3.56 2 888 700
2022-01-05 $3.76 $3.77 $3.52 $3.53 2 646 451
2022-01-04 $3.94 $3.95 $3.65 $3.73 4 014 885
2022-01-03 $3.89 $4.01 $3.78 $3.98 2 222 910
2021-12-31 $3.86 $4.03 $3.84 $3.89 2 914 648
2021-12-30 $3.77 $3.91 $3.74 $3.88 2 720 182
2021-12-29 $3.79 $3.86 $3.70 $3.76 3 167 264
2021-12-28 $3.85 $4.01 $3.78 $3.82 3 677 606
2021-12-27 $4.16 $4.16 $3.85 $3.86 4 450 429
2021-12-23 $4.13 $4.24 $4.00 $4.16 4 364 162
2021-12-22 $4.33 $4.33 $4.13 $4.16 3 088 077
2021-12-21 $4.38 $4.46 $4.27 $4.29 3 606 423
2021-12-20 $4.17 $4.50 $4.14 $4.38 7 434 006
2021-12-17 $3.85 $4.34 $3.78 $4.28 7 839 711
2021-12-16 $4.07 $4.15 $3.88 $3.89 4 531 898
2021-12-15 $4.12 $4.12 $3.80 $4.09 5 178 243
2021-12-14 $4.25 $4.58 $4.02 $4.14 8 353 291
2021-12-13 $4.38 $4.50 $4.14 $4.36 7 765 667
2021-12-10 $4.50 $4.67 $4.11 $4.14 7 097 437
2021-12-09 $4.11 $4.60 $4.08 $4.31 12 376 112
2021-12-08 $3.90 $4.26 $3.83 $4.14 7 967 966
2021-12-07 $3.98 $4.10 $3.79 $3.96 19 867 597
2021-12-06 $3.99 $4.01 $3.54 $3.71 10 061 352
2021-12-03 $4.05 $4.45 $3.92 $4.15 18 236 827
2021-12-02 $4.97 $5.23 $4.11 $4.31 72 563 715
2021-12-01 $5.15 $6.50 $4.13 $4.61 322 127 014
2021-11-30 $3.10 $3.23 $3.01 $3.20 1 475 983
2021-11-29 $3.20 $3.20 $3.08 $3.14 1 232 659
2021-11-26 $3.18 $3.21 $3.07 $3.13 651 802
2021-11-24 $3.11 $3.21 $3.05 $3.19 720 172
2021-11-23 $3.10 $3.14 $3.02 $3.12 1 288 763
2021-11-22 $3.27 $3.31 $3.09 $3.11 1 518 804
2021-11-19 $3.28 $3.37 $3.27 $3.30 924 125
2021-11-18 $3.40 $3.51 $3.27 $3.30 1 647 660
2021-11-17 $3.30 $3.37 $3.24 $3.29 1 093 547
2021-11-16 $3.32 $3.40 $3.25 $3.34 1 231 132
2021-11-15 $3.47 $3.47 $3.33 $3.36 1 304 908
2021-11-12 $3.50 $3.50 $3.34 $3.47 1 456 787
2021-11-11 $3.50 $3.55 $3.45 $3.47 827 703
2021-11-10 $3.47 $3.67 $3.46 $3.48 1 229 797
2021-11-09 $3.58 $3.65 $3.45 $3.50 1 408 381
2021-11-08 $3.50 $3.65 $3.46 $3.60 2 160 852
2021-11-05 $3.59 $3.70 $3.40 $3.48 3 637 730
2021-11-04 $3.90 $4.16 $3.84 $3.88 1 816 651

About Arbutus Biopharma Corporation

Arbutus Biopharma Arbutus Biopharma Corporation, a biopharmaceutical company, develops and commercializes therapeutics for the treatment of chronic hepatitis B (HBV) infections in Canada and the United States. It also develops a pipeline of products based on RNA interference therapeutics (RNAi). Its lead candidate is ARB-1467, a multi-component RNAi therapeutic product that is designed for the elimination of HBV surface antigen expression in patients chronically i... Read more

Golden Star Signal

This unique signal uses moving averages and adds special requirements that convert the very good Golden Cross into a Golden Star.

This signal is rare and, in most cases, gives substantial returns. From 10 000+ stocks usually only a few will trigger a Golden Star Signal per day!

Get access to Golden Star list now!

StockInvest.usJoin 100 000+ Happy Subscribers

Don't miss out on the runners!

Get The StockInvest.Us Newsletter

StockInvest.usStock Podcast

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT